Fortress Biotech
FBIO
#9379
Rank
ยฃ65.88 M
Marketcap
ยฃ2.12
Share price
2.91%
Change (1 day)
31.48%
Change (1 year)

Revenue for Fortress Biotech (FBIO)

Revenue in 2025 (TTM): ยฃ45.1 Million

According to Fortress Biotech 's latest financial reports the company's current revenue (TTM ) is ยฃ44.48 Million. In 2024 the company made a revenue of ยฃ45.95 Million a decrease over the revenue in the year 2023 that were of ยฃ66.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Fortress Biotech from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ45.1 M-1.85%
2024 ยฃ45.95 M-30.72%
2023 ยฃ66.33 M5.96%
2022 ยฃ62.6 M22.85%
2021 ยฃ50.96 M52.34%
2020 ยฃ33.45 M19.76%
2019 ยฃ27.93 M-125.66%
2018 -ยฃ0.11 Billion-178.43%
2017 ยฃ0.13 B939.21%
2016 ยฃ13.35 M2193.45%
2015 ยฃ0.58 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Advaxis
ADXS
ยฃ0.08 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
ยฃ0.37 B 734.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ0.14 B 225.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
ยฃ0.24 B 457.35%๐Ÿ‡บ๐Ÿ‡ธ USA